Reducing IL-2 signaling in T cells results in accelerated diabetes in mice due to defective regulatory T cell function.
No takes yet. Share an insight, caveat, or question.
Dwyer et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: